Engineering Pichia pastoris as a Heterologous Platform for Non-Ribosomal Peptide Biosynthesis of the β‑Lactam Intermediate δ‑(l‑α-Aminoadipyl)‑l‑cysteinyl‑d‑valine (ACV)
Shraddha Jogi, Rutuja Jagtap, Yalamanchili Venkata Subrahmanyam, Monika Sharma, Mahesh Kulkarni, Anu Raghunathan · 2026
Read Engineering Pichia pastoris as a Heterologous Platform for Non-Ribosomal Peptide Biosynthesis of the β‑Lactam Intermediate δ‑(l‑α-Aminoadipyl)‑l‑cysteinyl‑d‑valine (ACV) by Shraddha Jogi, Rutuja Jagtap, Yalamanchili Venkata Subrahmanyam, Monika Sharma, Mahesh Kulkarni, Anu Raghunathan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13261468.txt.
Description
Jogi and co-authors report in 2026 the first build of an antibiotic precursor path inside a yeast that is easy to engineer. The target compound, called ACV, is the first step toward penicillin type drugs. Making such peptides in foreign hosts is hard due to large, complex enzymes.
They placed tuned copies of two genes into the yeast genome to rebuild the minimal path. Chemical tests confirmed ACV output, at first only a few units per volume. Adaptive evolution raised yields ten fold, and feeding precursors helped a bit more. Gene reads showed the yeast reshaped its metabolism to meet the new demands.
Catalog record
| CREATOR | Shraddha Jogi, Rutuja Jagtap, Yalamanchili Venkata Subrahmanyam, Monika Sharma, Mahesh Kulkarni, Anu Raghunathan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 42 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |